Crown Bioscience, a wholly owned subsidiary of Crown Bioscience International (TWSE: ticker 6554) and a global drug discovery and development service
Crown Bioscience, a wholly-owned subsidiary of Crown Bioscience International (TWSE: ticker 6554) and a global drug discovery and development services
Cnano Technology phase two project successfully completed by government leaders and Cnano colleagues, scheduled completion of expansion plans.
Prof. Sumio Iijima, the discoverer of carbon nanotubes, will come to China to participate in the 2017 Nano-Carbon Materials Science Frontier and
Mountains of slag all over the world are a Kiwi company's idea of great riches.
Applied BioCode announced that it has signed a Partnership and Supply Agreement with Diatherix Laboratories, LLC, a Eurofins company.
Applied BioCode is pleased to announce that they have been accepted for listing on the Taiwan Emerging Market Stock Exchange (ticker symbol 6598).